Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 96

1.

A phase I-II study on the combination of rapamycin and short course radiotherapy in rectal cancer.

Buijsen J, van den Bogaard J, Jutten B, Belgers E, Sosef M, Leijtens JW, Beets GL, Jansen RL, Riedl RG, Clarijs R, Lammering G, Lambin P.

Radiother Oncol. 2015 Aug;116(2):214-20. doi: 10.1016/j.radonc.2015.07.039. Epub 2015 Aug 4.

2.

Selection of appropriate end-points (pCR vs 2yDFS) for tailoring treatments with prediction models in locally advanced rectal cancer.

Valentini V, van Stiphout RG, Lammering G, Gambacorta MA, Barba MC, Bebenek M, Bonnetain F, Bosset JF, Bujko K, Cionini L, Gerard JP, Rödel C, Sainato A, Sauer R, Minsky BD, Collette L, Lambin P.

Radiother Oncol. 2015 Mar;114(3):302-9. doi: 10.1016/j.radonc.2015.02.001. Epub 2015 Feb 21.

PMID:
25716096
3.

Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapy.

van Gijn W, van Stiphout RG, van de Velde CJ, Valentini V, Lammering G, Gambacorta MA, Påhlman L, Bujko K, Lambin P.

Ann Oncol. 2015 May;26(5):928-35. doi: 10.1093/annonc/mdv023. Epub 2015 Jan 21.

PMID:
25609247
4.

Treatment of acromegaly patients with risk-adapted single or fractionated stereotactic high-precision radiotherapy: High local control and low toxicity in a pooled series.

Boström JP, Kinfe T, Meyer A, Pintea B, Gerlach R, Surber G, Lammering G, Hamm K.

Strahlenther Onkol. 2015 Jun;191(6):477-85. doi: 10.1007/s00066-014-0802-2. Epub 2015 Jan 10.

PMID:
25575977
5.

Image-guided stereotactic ablative radiotherapy for the liver: a safe and effective treatment.

Van De Voorde L, Vanneste B, Houben R, Damen P, van den Bogaard J, Lammering G, Dejong K, de Vos-Geelen J, Buijsen J, Öllers M, Berbée M, Lambin P.

Eur J Surg Oncol. 2015 Feb;41(2):249-56. doi: 10.1016/j.ejso.2014.10.053. Epub 2014 Nov 1.

PMID:
25468743
6.

Nomogram predicting response after chemoradiotherapy in rectal cancer using sequential PETCT imaging: a multicentric prospective study with external validation.

van Stiphout RG, Valentini V, Buijsen J, Lammering G, Meldolesi E, van Soest J, Leccisotti L, Giordano A, Gambacorta MA, Dekker A, Lambin P.

Radiother Oncol. 2014 Nov;113(2):215-22. doi: 10.1016/j.radonc.2014.11.002. Epub 2014 Nov 20.

7.

Risk-adapted single or fractionated stereotactic high-precision radiotherapy in a pooled series of nonfunctioning pituitary adenomas: high local control and low toxicity.

Boström JP, Meyer A, Pintea B, Gerlach R, Surber G, Lammering G, Hamm K.

Strahlenther Onkol. 2014 Nov;190(12):1095-103. doi: 10.1007/s00066-014-0715-0. Epub 2014 Aug 5.

8.

Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer.

Buijsen J, van Stiphout RG, Menheere PP, Lammering G, Lambin P.

Radiother Oncol. 2014 May;111(2):237-42. doi: 10.1016/j.radonc.2014.03.006. Epub 2014 Apr 16.

PMID:
24746569
9.

Interobserver reproducibility of diffusion-weighted MRI in monitoring tumor response to neoadjuvant therapy in esophageal cancer.

Kwee RM, Dik AK, Sosef MN, Berendsen RC, Sassen S, Lammering G, Clarijs R, Oostenbrug LE, Blom RL, Vliegen RF.

PLoS One. 2014 Apr 4;9(4):e92211. doi: 10.1371/journal.pone.0092211. eCollection 2014.

10.

Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.

Matuschek C, Lehnhardt M, Gerber PA, Poremba C, Hamilton J, Lammering G, Orth K, Budach W, Bojar H, Bölke E, Peiper M.

Eur J Med Res. 2014 Feb 3;19:6. doi: 10.1186/2047-783X-19-6.

11.

Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.

Boström JP, Seifert M, Greschus S, Schäfer N, Glas M, Lammering G, Herrlinger U.

Strahlenther Onkol. 2014 Apr;190(4):416-21. doi: 10.1007/s00066-013-0505-0. Epub 2014 Jan 17.

PMID:
24429478
12.

Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?

Heijnen LA, Lambregts DM, Martens MH, Maas M, Bakers FC, Cappendijk VC, Oliveira P, Lammering G, Riedl RG, Beets GL, Beets-Tan RG.

Eur Radiol. 2014 Feb;24(2):371-9. doi: 10.1007/s00330-013-3016-6. Epub 2013 Sep 20.

PMID:
24051676
13.

Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma.

Blom RL, Sosef MN, Nap M, Lammering G, van den Berkmortel F, Hulshof MC, Meijer SL, Wilmink HW, van Berge Henegouwen MI.

Dis Esophagus. 2014 May-Jun;27(4):380-7. doi: 10.1111/dote.12110. Epub 2013 Sep 5.

PMID:
24006852
14.

Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?

Sassen S, de Booij M, Sosef M, Berendsen R, Lammering G, Clarijs R, Bakker M, Beets-Tan R, Warmerdam F, Vliegen R.

Eur Radiol. 2013 Dec;23(12):3440-9. doi: 10.1007/s00330-013-2956-1. Epub 2013 Jul 6.

PMID:
23832319
15.

What to choose as radical local treatment for lung metastases from colo-rectal cancer: surgery or radiofrequency ablation?

Schlijper RC, Grutters JP, Houben R, Dingemans AM, Wildberger JE, Van Raemdonck D, Van Cutsem E, Haustermans K, Lammering G, Lambin P, De Ruysscher D.

Cancer Treat Rev. 2014 Feb;40(1):60-7. doi: 10.1016/j.ctrv.2013.05.004. Epub 2013 Jun 13. Review.

PMID:
23768754
16.

PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.

Blom RL, Steenbakkers IR, Lammering G, Vliegen RF, Belgers EJ, de Jonge C, Schreurs WM, Nap M, Sosef MN.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1500-6. doi: 10.1007/s00259-013-2468-x. Epub 2013 Jun 14.

PMID:
23764889
17.

Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.

Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, Hixson R, Rosenstein BS, Ostrer H.

Radiother Oncol. 2013 Jun;107(3):372-6. doi: 10.1016/j.radonc.2013.05.001. Epub 2013 May 26.

18.

Phase I trial of the combination of the Akt inhibitor nelfinavir and chemoradiation for locally advanced rectal cancer.

Buijsen J, Lammering G, Jansen RL, Beets GL, Wals J, Sosef M, Den Boer MO, Leijtens J, Riedl RG, Theys J, Lambin P.

Radiother Oncol. 2013 May;107(2):184-8. doi: 10.1016/j.radonc.2013.03.023. Epub 2013 May 3.

PMID:
23647753
19.

Active breathing control in combination with ultrasound imaging: a feasibility study of image guidance in stereotactic body radiation therapy of liver lesions.

Bloemen-van Gurp E, van der Meer S, Hendry J, Buijsen J, Visser P, Fontanarosa D, Lachaine M, Lammering G, Verhaegen F.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1096-102. doi: 10.1016/j.ijrobp.2012.08.016. Epub 2012 Oct 8.

20.

A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.

Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS.

Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e21-8. doi: 10.1016/j.ijrobp.2012.08.003. Epub 2012 Sep 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk